benzyloxycarbonyl-phe-ala-fluormethylketone has been researched along with fluticasone furoate in 1 studies
Studies (benzyloxycarbonyl-phe-ala-fluormethylketone) | Trials (benzyloxycarbonyl-phe-ala-fluormethylketone) | Recent Studies (post-2010) (benzyloxycarbonyl-phe-ala-fluormethylketone) | Studies (fluticasone furoate) | Trials (fluticasone furoate) | Recent Studies (post-2010) (fluticasone furoate) |
---|---|---|---|---|---|
5 | 0 | 5 | 252 | 134 | 204 |
Protein | Taxonomy | benzyloxycarbonyl-phe-ala-fluormethylketone (IC50) | fluticasone furoate (IC50) |
---|---|---|---|
Glucocorticoid receptor | Homo sapiens (human) | 0.0004 | |
Progesterone receptor | Homo sapiens (human) | 0.021 | |
Mineralocorticoid receptor | Homo sapiens (human) | 0.166 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 1.88 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Johnson, BM; Meanwell, NA; Shu, YZ; Zhuo, X | 1 |
1 other study(ies) available for benzyloxycarbonyl-phe-ala-fluormethylketone and fluticasone furoate
Article | Year |
---|---|
Metabolic and Pharmaceutical Aspects of Fluorinated Compounds.
Topics: Drug Design; Fluorine; Halogenation; Humans; Pharmaceutical Preparations | 2020 |